Produkty 11021-13-9

CAS 11021-13-9 występuje w naszej ofercie pod nazwami: Ginsenoside rb2, 95%, Ginsenoside Rb2 , Ginsenoside Rb2, >95% (HPLC), Ginsenoside Rb2, Ginsenoside Rb2/ 99.66% (existing batch purity). Oferty producentów: Combi-blocks, Chemat Brand, TRC, GLPBio, TargetMol. Dostępne opakowania: 100mg, 250mg, on request, 10mg, 25mg, 20mg, 50mg, 1g.

Ginsenoside rb2, 95%
Combi-blocks
  • opakowanie: 100mg, 250mg
  • Warianty: 2
Zobacz produkt
Ginsenoside Rb2
Chemat Brand, Biosynth, Sigma-Aldrich
  • opakowanie: on request, 25mg, 10mg, 50mg
  • Warianty: 7
od 2682,00
Zobacz produkt
Ginsenoside Rb2, >95% (HPLC)
TRC
  • opakowanie: 10mg, 25mg
  • Warianty: 2
Zobacz produkt
Ginsenoside Rb2
GLPBio
  • opakowanie: 20mg
  • Warianty: 1
od 1055,73
Zobacz produkt
Ginsenoside Rb2/ 99.66% (existing batch purity)
TargetMol
  • opakowanie: 20mg
  • Warianty: 1
od 764,59
Zobacz produkt
Ginsenoside Rb2 99%
Ambeed
  • opakowanie: 50mg, 100mg, 250mg, 1g
  • Warianty: 4
od 943,31
Zobacz produkt
Ginsenoside Rb2 (Standard)
MedChemExpress
  • opakowanie: Get quote
  • Warianty: 1
Zobacz produkt
Ginsenoside Rb2, 99.87%
MedChemExpress
  • opakowanie: 50 mg, 10 mg, 100 mg, 25 mg
  • Warianty: 6
od 389,35
Zobacz produkt
Ginsenoside Rb2, ROTICHROM® HPLC, 10 mg, glass
Roth
  • opakowanie: 10mg
  • Warianty: 1
od 3185,74
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol (CAS 11021-13-9) to związek chemiczny o wzorze sumarycznym C53H90O22 i masie molowej 1079.3 g/mol. Nazwa systematyczna IUPAC: (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol. InChIKey: NODILNFGTFIURN-GZPRDHCNSA-N.

Dane identyfikacyjne
Wzór sumarycznyC53H90O22
Masa molowa1079.3 g/mol
Nazwa IUPAC(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
InChIKeyNODILNFGTFIURN-GZPRDHCNSA-N
SMILESCC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO[C@H]8[C@@H]([C@H]([C@H](CO8)O)O)O)O)O)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Ginsenoside Rb2, Ginsenoside C, gingenoside C, Ginsenoside-Rb2, (20S)-ginsenoside Rb2, GinsenosideRb2, NODILNFGTFIURN-GZPRDHCNSA-N, 20(S)-ginsenoside Rb2, Ginsenoside Rb2 (Standard), orb1222874
Powiązane formy tego związku
(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol C53H90O22
Izomery (ten sam wzór sumaryczny)
(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-17-[(2S)-2-[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-6-methylhept-5-en-2-yl]-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol C53H90O22